Enlivex Therapeutics Ltd. (NASDAQ: ENLV) announced that its primary treasury asset, the RAIN token, has been listed on the Kraken cryptocurrency exchange effective February 9, 2026. The move adds a second U.S.‑based venue to the company’s growing digital‑asset portfolio, expanding access for institutional and retail investors alike.
Kraken, the second‑largest U.S. cryptocurrency exchange, serves more than 5.7 million users and handles over $2 trillion in trading volume. By listing RAIN on Kraken, Enlivex aims to improve price discovery, increase secondary‑market liquidity, and provide a more robust platform for its treasury‑management strategy.
The announcement comes as Enlivex continues to pursue its dual strategy of advancing a macrophage‑reprogramming therapy while treating its treasury as a digital‑asset investment. The company stated that the listing will support its goal of maintaining a diversified, high‑yield treasury reserve that can be used to fund future clinical development or other corporate initiatives.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.